DEA Seeks Input on Executive Order

In January of 2017, shortly after he took office, President Donald Trump signed Executive Order 13771, which stipulates that, for each new federal regulation created, at least two must be eliminated. The executive order was drafted with the goal of “controlling regulatory costs,” but, as with many such orders, it raises considerable questions as it’s implemented. More specifically, how will it impact federal agencies, and, by extension, how will it affect professionals who operate under these regulations in their daily practice?

For its part, the Drug Enforcement Administration (DEA) is actively seeking public feedback on Executive Order 13771. During a public listening session in late August, Michael Lewis, who heads the agency’s Regulatory Drafting and Policy Section, sought to open an ongoing dialogue with members of the health care community about the executive order. Simply put, while there are some regulations that remain highly relevant and useful, others are outdated, and may do little more than create extra paperwork for professionals.

With that in mind, CTeL encourages members of the telehealth community to join the conversation as the DEA and other federal agencies continue to work to implement the executive order. We plan on submitting written comments to the DEA, and need your input in the following areas:

  • What current federal regulations do you consider to be outdated, unnecessary, and/or ineffective?
  • More specifically, are there regulations that stifle job creation/growth? Or for which the costs of adhering to them outweighs the benefits? Are there any that are inconsistent with regulatory reform initiatives?
  • What regulations should not be targeted for elimination—i.e., regulations that continue to be useful/relevant to your practice?

Please submit your comments to christanatoli@ctel.org. Thank you for being a part of this ongoing dialogue.

 

Share

Leave a Reply